Literature DB >> 15325566

Adenoviral-mediated gene transfer to retinal explants during development and degeneration.

Jijing Pang1, Mei Cheng, Douglas Stevenson, Melvin D Trousdale, C Kathleen Dorey, Janet C Blanks.   

Abstract

Naturally occurring mutations of the beta subunit of the cyclic guanosine monophosphate (cGMP) phosphodiesterase (beta-PDE) gene in rod photoreceptors of mice and dogs are similar to one of the inherited retinal degenerations termed retinitis pigmentosa in humans. Defects in the rod beta-PDE gene leading to photoreceptor cell degeneration in retinal degenerative (rd) mice can be corrected by transfer of a wild type beta-PDE gene. However, the rapid photoreceptor degeneration in this mutant makes the study of gene therapy difficult. Since the retinal degeneration is slowed in vitro, we have employed retinal explants from rd mice to study factors influencing viral transduction. Retinal explants provide a rapid, efficient method to compare the transduction efficiency of adenoviral vector-mediated reporter gene delivery at different ages in normal and rd mice. Retinal explants from postnatal day (P)2 to P28 control (C57BL/6J) and P2-P42 rd mice were exposed for 20 hr to 2.5 x 10(8) plaque forming units (pfu) ml(-1) of adenoviral vector with a beta-galactosidase (Lac Z) reporter gene (Ad-CMV-Lac Z). After incubation in vector-free media for an additional 3 days, the explants were fixed and histochemically stained for beta-galactosidase to reveal Lac Z gene expression. The explants were also embedded and sectioned for light microscopic observation. Transduction efficiency was higher in rd mice than in controls on all postnatal days examined. In normal retinal explants, expression of the Lac Z gene increased from P2 to a peak around P7-P8, then decreased at subsequent ages; little transduction could be found after P17. In rd mice transduction efficiency of Ad-CMV-Lac Z increased from P2 to P7, decreased by P10 and increased again after P10. The most dramatic increase in the transduction efficiency occurred in the rd retina between P10 and P15 when Lac Z was intensely expressed throughout the retina. Microscopic examination of retinal sections revealed the types and distribution of Lac Z-positive cells responsible for the deep blue staining in the retinal whole mount. In normal and rd mice, Lac Z-positive cells were located throughout the retina. However, larger numbers of Lac Z-positive cells were present at all ages examined in retinal explants from rd mice compared to normal mice. These data indicate a difference in transduction efficiency between normal and rd mice, especially after P12, and suggest efficient adenovirus-mediated gene transfer is more attainable in developing or degenerating retina. Thus, transduction efficiency in rd mice depends on the relationship between development, maturation and the degenerative state of the photoreceptor cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15325566     DOI: 10.1016/j.exer.2004.03.010

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  10 in total

1.  Evidence for retinal remodelling in retinitis pigmentosa caused by PDE6B mutation.

Authors:  Samuel G Jacobson; Alexander Sumaroka; Tomas S Aleman; Artur V Cideciyan; Michael Danciger; Debora B Farber
Journal:  Br J Ophthalmol       Date:  2007-05       Impact factor: 4.638

Review 2.  A review of in vivo animal studies in retinal prosthesis research.

Authors:  Dimiter R Bertschinger; Evgueny Beknazar; Manuel Simonutti; Avinoam B Safran; José A Sahel; Serge G Rosolen; Serge Picaud; Joel Salzmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-16       Impact factor: 3.117

3.  Long-term retinal function and structure rescue using capsid mutant AAV8 vector in the rd10 mouse, a model of recessive retinitis pigmentosa.

Authors:  Ji-jing Pang; Xufeng Dai; Shannon E Boye; Ilaria Barone; Sanford L Boye; Song Mao; Drew Everhart; Astra Dinculescu; Li Liu; Yumiko Umino; Bo Lei; Bo Chang; Robert Barlow; Enrica Strettoi; William W Hauswirth
Journal:  Mol Ther       Date:  2010-12-07       Impact factor: 11.454

4.  AAV-mediated lysophosphatidylcholine acyltransferase 1 (Lpcat1) gene replacement therapy rescues retinal degeneration in rd11 mice.

Authors:  Xufeng Dai; Juanjuan Han; Yan Qi; Hua Zhang; Lue Xiang; Jineng Lv; Jie Li; Wen-Tao Deng; Bo Chang; William W Hauswirth; Ji-jing Pang
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

Review 5.  Barriers for retinal gene therapy: separating fact from fiction.

Authors:  Rajendra Kumar-Singh
Journal:  Vision Res       Date:  2008-06-18       Impact factor: 1.886

6.  Development of a murine ocular posterior segment explant culture for the study of intravitreous vector delivery.

Authors:  Nora Denk; Vikram Misra; Lynne S Sandmeyer; Bianca B Bauer; Jaswant Singh; George W Forsyth; Bruce H Grahn
Journal:  Can J Vet Res       Date:  2015-01       Impact factor: 1.310

7.  Retinal transduction profiles by high-capacity viral vectors.

Authors:  A Puppo; G Cesi; E Marrocco; P Piccolo; S Jacca; D M Shayakhmetov; R J Parks; B L Davidson; S Colloca; N Brunetti-Pierri; P Ng; G Donofrio; A Auricchio
Journal:  Gene Ther       Date:  2014-07-03       Impact factor: 5.250

Review 8.  Has retinal gene therapy come of age? From bench to bedside and back to bench.

Authors:  Ivana Trapani; Alberto Auricchio
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

Review 9.  Gene therapy of inherited retinal degenerations: prospects and challenges.

Authors:  Ivana Trapani; Sandro Banfi; Francesca Simonelli; Enrico M Surace; Alberto Auricchio
Journal:  Hum Gene Ther       Date:  2015-04       Impact factor: 5.695

Review 10.  Vector platforms for gene therapy of inherited retinopathies.

Authors:  Ivana Trapani; Agostina Puppo; Alberto Auricchio
Journal:  Prog Retin Eye Res       Date:  2014-08-12       Impact factor: 21.198

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.